Nautilus Biotechnology Inc (NAUT)
2.95
+0.03
(+1.03%)
USD |
NASDAQ |
May 17, 16:00
2.95
0.00 (0.00%)
After-Hours: 20:00
Nautilus Biotechnology Total Liabilities (Quarterly): 39.16M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 39.16M |
| December 31, 2023 | 40.21M |
| September 30, 2023 | 41.06M |
| June 30, 2023 | 41.09M |
| March 31, 2023 | 42.17M |
| December 31, 2022 | 35.13M |
| September 30, 2022 | 33.97M |
| Date | Value |
|---|---|
| June 30, 2022 | 34.15M |
| March 31, 2022 | 34.96M |
| December 31, 2021 | 34.87M |
| September 30, 2021 | 7.50M |
| June 30, 2021 | 3.231M |
| December 31, 2020 | 114.73M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.231M
Minimum
Jun 2021
114.73M
Maximum
Dec 2020
38.63M
Average
35.13M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 591.10M |
| Geron Corp | 137.21M |
| TG Therapeutics Inc | 213.21M |
| Editas Medicine Inc | 145.95M |
| G1 Therapeutics Inc | 74.29M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 288.65M |
| Shareholders Equity (Quarterly) | 249.49M |